| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 77 |
| 1 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 75 |
| 2 | TACROLIMUS OINTMENT 0.1% | 75 |
| 3 | MYCOPHENOLATE MOFETIL | 68 |
| 4 | PREDNISONE | 45 |
| 5 | PREDNISOLONE | 40 |
| 6 | PREDNISOLONE ORAL | 40 |
| 7 | PREDNISOLONE ORAL SOLUTION | 40 |
| 8 | METHOTREXATE SODIUM | 39 |
| 9 | METHYLPREDNISOLONE | 36 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | FLUCYTOSINE | 6 | 0.0042 |
| 1 | ELAPEGADEMASE-LVLR | 1 | 0.0033 |
| 2 | ANIDULAFUNGIN | 4 | 0.0025 |
| 3 | DAUNORUBICIN HYDROCHLORIDE | 3 | 0.0018 |
| 4 | ALLOPURINOL SODIUM | 1 | 0.0018 |
| 5 | CLOFARABINE | 4 | 0.0017 |
| 6 | MITOXANTRONE HYDROCHLORIDE | 10 | 0.0016 |
| 7 | PYRIMETHAMINE | 2 | 0.0016 |
| 8 | CASPOFUNGIN ACETATE | 2 | 0.0013 |
| 9 | AMPHOTERICIN B | 14 | 0.0011 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 123 |
| 1 | Azole Antifungal [EPC] | 49 |
| 2 | Alkylating Drug [EPC] | 39 |
| 3 | Nucleoside Metabolic Inhibitor [EPC] | 37 |
| 4 | Folate Analog Metabolic Inhibitor [EPC] | 35 |
| 5 | Kinase Inhibitor [EPC] | 35 |
| 6 | Polyene Antifungal [EPC] | 16 |
| 7 | Topoisomerase Inhibitor [EPC] | 16 |
| 8 | Calcineurin Inhibitor Immunosuppressant [EPC] | 15 |
| 9 | Lipid-based Polyene Antifungal [EPC] | 15 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Nucleoside Analog Antifungal [EPC] | 6 | 0.0042 |
| 1 | Dihydrofolate Reductase Inhibitor Antimalarial [EPC] | 2 | 0.0016 |
| 2 | Echinocandin Antifungal [EPC] | 11 | 0.0013 |
| 3 | Lipid-based Polyene Antifungal [EPC] | 15 | 0.0012 |
| 4 | Adrenocorticotropic Hormone [EPC] | 1 | 0.0011 |
| 5 | Sulfonamide Antibacterial [EPC] | 3 | 0.0008 |
| 6 | Interferon gamma [EPC] | 1 | 0.0007 |
| 7 | CD33-directed Immunoconjugate [EPC] | 2 | 0.0005 |
| 8 | Antimetabolite Immunosuppressant [EPC] | 11 | 0.0005 |
| 9 | Polyene Antifungal [EPC] | 16 | 0.0004 |